Regional differences in overall survival (OS) in patients with advanced melanoma (MEL) who received nivolumab (NIVO) combined with ipilimumab (IPI) or NIVO alone in a phase 3 trial (CheckMate 067)

被引：0

作者：

Grob, J-J. ^{[1
]}

Schadendorf, D. ^{[2
]}

Wagstaff, J. ^{[3
]}

Marquez-Rodas, I. ^{[4
]}

Lebbe, C. ^{[5
,6
]}

Ascierto, P. A. ^{[7
]}

Hodi, F. S. ^{[8
]}

Grossmann, K. ^{[9
]}

Hassel, J. C. ^{[10
,11
,12
]}

Walker, D. ^{[13
]}

Bhore, R. ^{[13
]}

Larkin, J. ^{[14
]}

Wolchok, J. D. ^{[15
,16
]}

机构：

[1] Hosp Timone, Dermatol, Marseille, France

[2] Univ Essen Gesamthsch, Dept Dermatol, Essen, Germany

[3] Singleton Hosp, South West Wales Canc Inst, Med Oncol, Swansea, W Glam, Wales

[4] Hosp Gen Univ Gregorio Maranon, Serv Oncol Med, Madrid, Spain

[5] Univ Paris Diderot, Hop St Louis, AP HP, Dermatol Dept,INSERM,U976, Paris, France

[6] Univ Paris Diderot, Hop St Louis, CIC Dept, INSERM,U976, Paris, France

[7] Fdn Pascale, Dept Med Oncol, Ist Nazl Tumori, Naples, Italy

[8] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA

[9] Huntsman Canc Inst, Oncol, Salt Lake City, UT USA

[10] Univ Hosp Heidelberg, Dept Dermatol, Heidelberg, Germany

[11] Univ Hosp Heidelberg, NCT, Heidelberg, Germany

[12] Natl Ctr Tumor Dis, Heidelberg, Germany

[13] Bristol Myers Squibb, Oncol, Princeton, NJ USA

[14] Royal Marsden Hosp, Dept Med Oncol, London, England

[15] Mem Sloan Kettering Canc Ctr, Oncol, 1275 York Ave, New York, NY 10021 USA

[16] Weill Cornell Med Coll, New York, NY USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1222PD

引用

页数：2